Omeros (OMER) EBITDA Margin (2010 - 2026)
Omeros' EBITDA Margin was 0.94% in Q2 2026, up 174.61 percentage points from the prior quarter.
Powered by 
Analysis
Omeros (OMER) EBITDA Margin (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Omeros' EBITDA Margin was -187.17% through Jun 30, 2026, up 42.42 percentage points year-over-year; for FY2020, it was -210.40%, down 81.39 percentage points from FY2019.
- EBITDA Margin shows a five-year change of +315.39 percentage points (FY2015 to FY2020).
- In earlier years, EBITDA Margin was -129.01% in FY2019 (+243.37 pp), -372.38% in FY2018 (-305.58 pp), -66.79% in FY2017 (+62.90 pp) and -129.70% in FY2016 (+396.09 pp).
- The Q2 2026 figure marks the highest quarterly EBITDA Margin in data going back to Q3 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Omeros | 1.40 Bn | 1.40 Bn | 27.73 Mn | 0.94% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.94% |
| Mar 31, 2026 | -173.68% |
| Sep 30, 2021 | -131.74% |
| Jun 30, 2021 | -156.85% |
| Mar 31, 2021 | -213.14% |
| Dec 31, 2020 | -314.32% |
| Sep 30, 2020 | -95.84% |
| Jun 30, 2020 | -201.63% |
| Mar 31, 2020 | -98.89% |
| Dec 31, 2019 | -69.44% |
| Sep 30, 2019 | -35.84% |
| Jun 30, 2019 | -33.22% |
| Mar 31, 2019 | -86.61% |
| Dec 31, 2018 | -82.55% |
| Sep 30, 2018 | -763.26% |
| Jun 30, 2018 | -1,837.52% |
| Mar 31, 2018 | -1,729.60% |
| Dec 31, 2017 | -101.01% |
| Sep 30, 2017 | -22.93% |
| Jun 30, 2017 | -68.92% |
API Access
Omeros EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OMER&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "OMER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OMER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();